Moderna

Moderna

American biotechnology company

Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".

Also known as...Moderna, Inc., Moderna Therapeutics, and Moderna Therapeutics, Inc.
Moderna-Merck cancer vaccine trial succeeds

Moderna-Merck cancer vaccine trial succeeds Moderna-Merck melanoma vaccine cuts recurrence risk by 50% in Phase 3 trial.